Always Learning Fool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Author Bio Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. He served on active duty with the US Army and has a Bachelor's degree in accounting. Follow @dannyvena There's little doubt that the pandemic has given online retail a huge boost. While the rate of adoption may slow, e-commerce is clearly a part of everyday life. It's also apparent that a company with a sticky ecosystem that offers more than just online purchasing is increasing its chances of long-term success. On thi...

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights Pfizer's (NYSE:PFE) share price actually fell a little after an advisory committee to the U.S. Food and Drug Administration (FDA) recommended Emergency Use Authorization (EUA) for its COVID-19 vaccine last week. Moderna (NASDAQ:MRNA) has its turn on Thursday with the same co...